1. Miguel-Vicedo M, Cabello P, Ortega-Navas MC, González-Barrio D, Fuentes I. Prevalence of Human Toxoplasmosis in Spain Throughout the Three Last Decades (1993-2023): A Systematic Review and Meta-analysis. J Epidemiol Glob Health. 2024 ;14(3):621-637. [DOI:10.1007/s44197-024-00258-w] [PMID] []

2. Wilking H, Thamm M, Stark K, Aebischer T, Seeber F. Prevalence, incidence estimations, and risk factors of Toxoplasma gondii infection in Germany: a representative, cross-sectional, serological study. Sci Rep. 2016;6:22551. [DOI:10.1038/srep22551] [PMID] []

3. Galeh TM, Sarvi S, Montazeri M, Moosazadeh M, Nakhaei M, Shariatzadeh SA, et al. Global Status of Toxoplasma gondii Seroprevalence in Rodents: A Systematic Review and Meta-Analysis. Front Vet Sci. 2020;7:461. [DOI:10.3389/fvets.2020.00461] [PMID] []

4. Daryani A, Sagha M, Sharif M, Dehghan MH, Ziaei H. Seroepidemiology of toxoplasmosis in women referred to Ardabil laboratory of health center for medical examinations before marriage, Iran, 2002. Int J Trop Med. 2006; 1(1):27-29.

5. Kanani B, Namaei M H, Tavakoli Kareshk A, Solgi R. Seroprevalence of Toxoplasma gondii Infection Among Women of Reproductive Age in Birjand, Iran. Mod Care J. 2022;19(4):e127872. [DOI:10.5812/modernc-127872]

6. Montazeri M, Mikaeili Galeh T, Moosazadeh M, Sarvi S, Dodangeh S, Javidnia J, et al. The global serological prevalence of Toxoplasma gondii in felids during the last five decades (1967-2017): a systematic review and meta-analysis. Parasit Vectors. 2020 ;13(1):82. [DOI:10.1186/s13071-020-3954-1] [PMID] []

7. Hashemi HJ, Saraei M. Seroprevalence of Toxoplasma gondii in unmarried women in Qazvin, Islamic Republic of Iran. East Mediterr Health J. 2010 ;16(1):24-8. [DOI:10.26719/2010.16.1.24]

8. Asfaram S, Rezaei R, Fakhar M, Ghezelbash B, Nakhaei M, Hezarjaribi HZ, et al. High occurrence of Toxoplasma gondii infection among blood donors in Ardabil Province as main focus of zoonotic visceral leishmaniosis, northwestern Iran. Ann Parasitol. 2021;67(4):611-617.

9. Sadegi Hariri S, Heidari Z, Habibzadeh S, Shahbazzadegan S. Seroprevalence of Toxoplasma gondii among Pregnant Women in Ardabil, Iran (2021-2022). Iran J Parasitol. 2023;18(1):93-99. [DOI:10.18502/ijpa.v18i1.12385] [PMID] []

10. Gharavi M J, Roozbehani M, Miahipour A, Oshaghi M, Gharegozlou B, Kalantar E, et al. Prevalence of Anti-Toxoplasma gondii Antibodies in Young Iranians: The CASPIAN III Study. Arch Pediatr Infect Dis. 2018;6(1):e61640. [DOI:10.5812/pedinfect.61640]

11. Foroutan M, Majidiani H, Hassanipour S, Badri M. Toxoplasma gondii seroprevalence in the Iranian blood donors: A systematic review and meta-analysis. Heliyon. 2024;10(6):e28013. [DOI:10.1016/j.heliyon.2024.e28013] [PMID] []

12. Kazemi F, Arjmand R, Dousti M, Fasihi Karami M, Barzegar G, Mohammadi A, et al. Toxoplasma and Risk of Spontaneous Abortion: A Meta-Analysis in A Population of Iranian Women. Int J Fertil Steril. 2023;17(1):7-11.

13. Asfaram S, Iranpour S, Molaei S, Abdollahzadeh H, Faraji F, Aminizadeh S. Sero-prevalence of Toxoplasma gondii before and during the COVID-19 pandemic in Northwestern Iran. BMC Infect Dis. 2024;24(1):834. [DOI:10.1186/s12879-024-09724-z] [PMID] []

14. van den Berg OE, Stanoeva KR, Zonneveld R, Hoek-van Deursen D, van der Klis FR, van de Kassteele J, et al. Seroprevalence of Toxoplasma gondii and associated risk factors for infection in the Netherlands: third cross-sectional national study. Epidemiol Infect. 2023;151:e136. [DOI:10.1017/S095026882300122X] [PMID] []

15. Dini FM, Morselli S, Marangoni A, Taddei R, Maioli G, Roncarati G, et al. Spread of Toxoplasma gondii among animals and humans in Northern Italy: A retrospective analysis in a One-Health framework. Food Waterborne Parasitol. 2023;32:e00197. [DOI:10.1016/j.fawpar.2023.e00197] [PMID] []

16. Molan A, Nosaka K, Hunter M, Wang W. Global status of Toxoplasma gondii infection: systematic review and prevalence snapshots. Trop Biomed. 2019;36(4):898-925.

17. Jones JL, Kruszon-Moran D, Wilson M, McQuillan G, Navin T, McAuley JB. Toxoplasma gondii infection in the United States: seroprevalence and risk factors. Am J Epidemiol. 2001;154(4):357-65. [DOI:10.1093/aje/154.4.357] [PMID]

18. Konishi E, Houki Y, Harano K, Mibawani RS, Marsudi D, Alibasah S, etal. High prevalence of antibody to Toxoplasma gondii among humans in Surabaya, Indonesia. Jpn J Infect Dis. 2000; 53:238-241.

19. Nasiru Wana M, Mohd Moklas MA, Watanabe M, Nordin N, Zasmy Unyah N, Alhassan Abdullahi S, et al. A Review on the Prevalence of Toxoplasma gondii in Humans and Animals Reported in Malaysia from 2008-2018. Int J Environ Res Public Health. 2020;17(13):4809. [DOI:10.3390/ijerph17134809] [PMID] []